User:Lan.wang17/Jon Zifferblatt

Jon Zifferblatt MD/MPH/MBA, is healthcare professional and Editor-in-Chief of the China Pharmaceutical and Biotechnology Review. He is the managing director of General Biologic (GBI), a Shanghai-based consulting and data intelligence company and currently serves as the Vice Chair of the Shanghai American Chamber of Commerce- Healthcare Committee. Previously, Zifferblatt was the VP of ChinaVest, a merchant bank based in Shanghai. He received his B.S. education from Stanford and a MBA/MPH from University of Berkeley's Haas School of Business.

Zifferblatt frequently speaks and writes about China's pharmaceutical and healthcare space. He is a regularly contributor for the Pharmaceutical Executive magazine. Zifferblatt was also interviewed in Swedish newswire, Sydsvenskan, about the impact of China's healthcare reform.